Suchergebnisse - "71050168A2"

PubPharm (3)

1

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

enthalten in: Blood advances | 2023

von Graf, S. | Lynch, R. | Ujjani, C. | +11

2

Long-time progression-free survival in relapsed, refractory multiple myeloma with the oral ixazomib-lenalidomide-dexamethasone regime

enthalten in: Orvosi hetilap | 2021

von Hardi, A. | Varga, G. | Nagy, Z. | +9

3

Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial : a multi-center study

enthalten in: Annals of hematology | 2020

von Li, J. | Bao, L. | Xia, Z. | +17

1
[1]